yingweiwo

New1

New1

New1 related products

Structure Cat No. Product Name CAS No. Product Description
BMS-919373 V12968 BMS-919373 1272353-82-8 BMS-919373 is a Potassium channel Kv1.5 (KCNA5) inhibitor for use in atrial fibrillation and acute coronary syndromes.
BMS-929075 V12969 BMS-929075 1217338-97-0 BMS-929075 is a potent orally bioactive palm site allosteric inhibitor of HCV (hepatitis C virus) NS5B replicase.
BMS-932481 V12970 BMS-932481 1263871-36-8 BMS-932481 is a novel and potent γ-secretase modulator
BMS-933043 V12971 BMS-933043 1221973-93-8 BMS-933043 is a novel and potent α7 nAChR Partial Agonist
BMS-955176 (GSK-3532795) V15284 BMS-955176 (GSK-3532795) 1392312-45-6 GSK3532795, formerly known as BMS955176, is a potent, orally bioavailable, second-generation HIV-1 maturation inhibitor (MI) that advanced through phase IIb clinical trials.
BMS-955176 HCl V13470 BMS-955176 HCl 2023808-13-9 GSK3532795 HCl, formerly known as BMS955176, is a potent, orally bioavailable, second-generation HIV-1 maturation inhibitor (MI) that advanced through phase IIb clinical trials.
BMS-955176 TFA V15285 BMS-955176 TFA 2097784-79-5 GSK3532795 TFA, formerly known as BMS955176, is a potent, orally bioavailable, second-generation HIV-1 maturation inhibitor (MI) that advanced through phase IIb clinical trials.
BMS-955829 V12972 BMS-955829 1375751-08-8 BMS-955829 is a novel and potent Positive allosteric modulators (PAMs)
BMS-960  free base V6241 BMS-960 free base 1265321-86-5 BMS-960 free base is a potent and selective S1P1 receptor agonist containing isoxazole, which can be used for research on immune diseases and vascular diseases[1]
BMS-961955 V12973 BMS-961955 1431328-92-5 BMS-961955 is a novel and potent inhibitor of NS5B polymerase
BMS-962212 V5682 BMS-962212 1430114-34-3 BMS-962212 is a novel, reversible, direct, and selective inhibitor of factor XIa (FXIa).
BMS-986034 V6662 BMS-986034 1492631-88-5 BMS-986034 is a novel and potent GPR119 agonist
BMS-986104 HCl V12977 BMS-986104 HCl 1622180-39-5 BMS-986104 HCl is a selective S1P1 receptor partial agonist.
BMS-986115 V12978 BMS-986115 1584647-27-7 BMS-986115 (Notch inhibitor 1) is a potent Notch inhibitor (antagonist) with IC50s of 7.8 and 8.5 nM for Notch 1 and Notch 3 respectively.
BMS-986118 V12979 BMS-986118 1610562-74-7 BMS-986118 is a potent, orally bioactive, selective GPR40 agonist with EC50 of 0.07 µM.
BMS-986122 V8558 BMS-986122 313669-88-4 BMS-986122 is a potent and selective positive allosteric modulator (PAM) of the μ-opioid receptor (μ-OR).
BMS-986124 V12981 BMS-986124 1447968-71-9 BMS-986124 is a novel, potent and allosteric modulator of the μ-Opioid Receptor.
BMS-986187 V12984 BMS-986187 684238-37-7 BMS-986187 is a delta opioid receptor-selective positive allosteric modulator (PAM) with EC50 of 0.03 μM and a pKB of 6.02 (~1 μM).
BMS-986188 V5752 BMS-986188 1776115-10-6 S-986188 is a selective positive allosteric modulator (PAM) of delta opioid receptors with EC50 of 0.05 μM.
BMS22 V12902 BMS22 445479-97-0 BMS22 (BMS-22; BMS CCR2 22) is a novel and potent CCR2 (CC-type chemokine receptor 2) antagonist with anti-inflammatory activity.
Contact Us